For media inquiries, contact:

info@nmdpbiotherapies.com

NMDP BioTherapies Relaunches Premium Services Supporting Autologous Cell Therapies

NMDP BioTherapies and the NMDP BioTherapies Cord Blood Bank Alliance Introduce Optimal Cord Blood Units for Manufacture of NK Cell Therapies And Other Cord Derived Cell Therapies

BlueSphere Bio To Partner with NMDP BioTherapies℠ for the Company’s First-In-Human TCR-based Product Candidate in Combination with Allogeneic Hematopoietic Cell Transplantation Trial

NMDP BioTherapies to Present Data at ISCT 2024 on the Stability of Infectious Disease Marker Analytes During Donor Qualification for Allogeneic Cell Therapies

NMDP BioTherapies Introduces Enhanced Cellular Materials for Allogeneic Cell Therapy Development

NMDP Announces Enrollment of First Patient in OPTIMIZE Clinical Trial

NMDP BioTherapies Appoints New President to Lead Next Phase in Life-Saving Therapy Development

NMDP BioTherapies and Cryoport Partner to Accelerate the Development of Cell and Gene Therapies

NMDP BioTherapies Marks Cord Blood Awareness Month with the Announcement of the Cord Blood Bank Alliance

NMDP BioTherapies To Provide Robust Cell Therapy Infrastructure to Support Garuda Therapeutics’ Potentially Ground-Breaking Off-The-Shelf Cell Therapies

NMDP and NMDP BioTherapies Mark Clinical Trials Day With New Resources and Services for Patients, Researchers, and Industry Sponsors

NMDP BioTherapies Launches CIBMTR CRO Services for Cell and Gene Therapy

Be The Match BioTherapies® Launches Bioinformatics Consulting Services

Be The Match BioTherapies® Expands Presence In the San Francisco Bay Area For Allogeneic Therapy Development and Commercialization

Be The Match BioTherapies® Now Offers A Central Point of Access To Fully-Characterized Cord Blood Units for Commercial and Clinical Use

Chimeric Partners with Be The Match BioTherapies to Advance CHM 1101 (CLTX CAR T)

Be The Match BioTherapies and Atara Biotherapeutics Announce Multi-Year Partnership Extension

Be The Match BioTherapies and Vineti collaborate to develop innovative, integrated supply chain management solutions for cell and gene therapies

Cellevolve Announces Global Partnership with QIMR to Advance Novel Off-the Shelf T-cell Therapy in the First Randomized Cell Therapy Trial for Progressive Multifocal Leukoencephalopathy (PML)

Be The Match BioTherapies Announces Expansion of Multi-Year Strategic Alliance with Orchard Therapeutics to Support European Commercial Launch of Libmeldy™

Lonza and Be The Match BioTherapies Partner to Expand Vein-to-Vein Cell and Gene Therapy Supply Chain Network

Gamida Cell and Be The Match BioTherapies Expand Strategic Collaboration

CIBMTR Completes Enrollment in Yescarta® Long-Term Post-Marketing Safety Study, 2 Years Ahead of Schedule

Be The Match BioTherapies and NantKwest Announce Collaboration to Accelerate Development of Cell Therapy to Prevent COVID-19 Deaths

Information Regarding Be The Match BioTherapies Response to COVID-19

Be The Match BioTherapies Leads Discussion During Phacilitate: Leaders World on Impact of Starting Material Quality

CIBMTR Announces Real World Data Effort to Accelerate Breakthroughs that Transform Patient Experiences in Cellular Therapy with IQVIA

Kite and the CIBMTR Present Positive Findings from Real-World Use of Yescarta® (Axicabtagene Ciloleucel) in Relapsed or Refractory Large B-cell Lymphoma

Gamida Cell and the CIBMTR Announce Collaboration to Advance Research for Life-Saving Cellular Therapy

Be The Match BioTherapies and Celyad Announce Collaboration to Advance Development of Allogeneic CAR-T Therapies

Be The Match BioTherapies and Tmunity Announce Collaboration to Support Clinical Trials of Next-Generation Immunotherapies

Be The Match BioTherapies Hosts Accellerate Summit Convening Top Industry Stakeholders to Progress Standardization Efforts

Be The Match BioTherapies and TrakCel Partner to Standardize Cell and Gene Therapy Supply Chain Solutions

Be The Match BioTherapies Announces Strategic Collaboration with Kiadis Pharma to Accelerate Patient Access to Haploidentical Stem Cell Therapies

Be The Match BioTherapies Announces Collaboration with Poseida Therapeutics to Support Development of Life-Saving Cellular Therapies

Gamida Cell and Be The Match BioTherapies Announce Strategic Collaboration

Be The Match BioTherapies Announces Collaboration with National Health Service Blood and Transplant of the United Kingdom

Be The Match BioTherapies Announces Launch of Quality System Audit Program (QSAP) to Enable Faster Onboarding of Cell Collection Facilities

Be The Match BioTherapies and Cryoport Announce Strategic Partnership to Deliver Integrated End-to-End Supply Chain Services to the Cell and Gene Therapy Industry

CIBMTR to Track Long-Term Outcomes Data for Kymriah®

Be The Match BioTherapies to Present at Three Upcoming Boston Conferences

Be The Match BioTherapies Strengthens Business Development Team With New Hires

CIBMTR Announces Collaboration with Kite to Track Long-Term Outcomes Data for YESCARTA®

Be The Match BioTherapies Strengthens Partnership with Magenta Therapeutics

Be The Match BioTherapies Expands Leadership Team with Promotions and New Hires

Be The Match BioTherapies Invests in Tmunity Therapeutics to Support Advancement of Next-Generation T Cell Immunotherapies

Be The Match BioTherapies Launches New Technology Platform for Cell Therapy Supply Chain Management

Associate Bioinformatics Scientist Participates in the First AI Genomics Hackathon

Be The Match BioTherapies Announces Collaboration Agreement with Magenta Therapeutics

National Marrow Donor Program (NMDP)/Be The Match Forms New Cellular Therapies Subsidiary